Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Astellas Venture Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Astellas Venture Management

Astellas Venture Management

Operating

California-based Astellas Venture Management: a leading biotechnology investment provider.

Location
Menlo Park, CA, US
Founded
2005
Firm
Compare
Portfolio
Employees
Website

Astellas Venture Management, based in California, focuses on investments in the biotechnology sector. The firm primarily participates in early-stage funding rounds, with a strong emphasis on Series A investments. Their portfolio spans a wide range of biotechnology companies, indicating a diverse approach within the sector.

Notable portfolio companies include Avilar Therapeutics, Carbon Biosciences, and Casma Therapeutics. Astellas Venture Management has invested in companies working on innovative therapies and technologies, such as Orna Therapeutics and TScan Therapeutics. The firm's investment strategy appears to target companies with high growth potential in the biotechnology space, supporting advancements in medical research and drug development.

Astellas Venture Management - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments25
Current Portfolio Count17
Total Portfolio Exits1

Top Investment Stages

Series A13 (52.0%)
Series B5 (20.0%)
Series Unknown3 (12.0%)
Seed2 (8.0%)
Series C2 (8.0%)

Stage Mix

Series A 52%Series B 20%Series Unknown 12%Seed 8%Series C 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Shinobi Therapeutics logo

Shinobi Therapeutics

Solu Therapeutics logo

Solu Therapeutics

Avilar Therapeutics logo

Avilar Therapeutics

Casma Therapeutics logo

Casma Therapeutics

DEM Biopharma logo

DEM Biopharma

Carbon Biosciences logo

Carbon Biosciences

Orna Therapeutics logo

Orna Therapeutics

Catamaran Bio logo

Catamaran Bio

TScan Therapeutics logo

TScan Therapeutics

Coda Biotherapeutics logo

Coda Biotherapeutics

Cleave Therapeutics logo

Cleave Therapeutics

Twentyeight-Seven Therapeutics logo

Twentyeight-Seven Therapeutics

Redona Therapeutics logo

Redona Therapeutics

Tizona Therapeutics logo

Tizona Therapeutics

Raze Therapeutics logo

Raze Therapeutics

DecImmune Therapeutics logo

DecImmune Therapeutics

PhaseBio Pharmaceuticals logo

PhaseBio Pharmaceuticals

Verastem logo

Verastem

PanOptica logo

PanOptica

Astellas Venture Management - Similar Investment Firms

Avalon BioVentures logo

Avalon BioVentures

Avestria logo

Avestria

avestria.vc

5AM Ventures logo

5AM Ventures

5amventures.com

Versant Ventures logo

Versant Ventures

Pivotal bioVenture Partners logo

Pivotal bioVenture Partners

Nest.Bio Venture logo

Nest.Bio Venture

nest.bio

Avalon Ventures logo

Avalon Ventures

Atlas Venture logo

Atlas Venture

atlasventure.com

Alta Partners logo

Alta Partners

altapartners.com

Asset Management Ventures logo

Asset Management Ventures

assetman.com

Healthcare Ventures logo

Healthcare Ventures

hcven.com

AbbVie Biotech Ventures logo

AbbVie Biotech Ventures

abbvie.com

VentureTech Alliance logo

VentureTech Alliance

vtalliance.com

Illumina Ventures logo

Illumina Ventures

Astia Angels logo

Astia Angels

astia.org

Astellas Venture Management - Classification

Also Known As
  • Astellas Venture Management LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end